We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ATENZA methylphenidate hydrochloride 54mg prolonged-release tablets (Spain)
Section 19A approved medicine
ATENZA methylphenidate hydrochloride 54mg prolonged-release tablets (Spain)
Section 19A approval holder
Arrotex Pharmaceuticals Pty Ltd ABN 30 605 552 234
Phone
1800 195 055
Approved until
Status
Current
Medicines in short supply/unavailable
CONCERTA methylphenidate hydrochloride 54mg modified release tablet bottle - ARTG 93864
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 54 mg modified release tablet bottle - ARTG 370899
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 54 mg modified release tablet bottle - ARTG 370899
Indication(s)
Indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Treatment should be commenced by a specialist.
Images